Skip to main content

Table 2 ACS subgroups Vs polymorphisms distribution

From: A synergic effect between CYP2C19*2, CYP2C19*3 loss-of-function and CYP2C19*17 gain-of-function alleles is associated with Clopidogrel resistance among Moroccan Acute Coronary Syndromes patients

Cases

P value (< 0.05)

CYP2C19*2

681G>A

GG %

GA %

AA %

G allele %

A allele %

0.002**

 ST (+)

4

80

16

44

56

 

 ST (−)

9.1

84.85

6.06

51.5

48.5

 

CYP2C19*3

636G>A

GG %

GA %

AA %

G allele  %

A allele %

0.04*

 ST (+)

5.26

73.68

21.06

42.1

57.9

 

 ST (−)

3.03

75.76

21.21

40.9

59.1

 

CYP2C19*17

− 806 C>T

CC %

CT %

TT %

C allele %

T allele %

0.3

 ST (+)

30

50

20

55

45

 

 ST (−)

10.87

69.57

19.56

47

53

 
  1. ST (+): Acute Coronary Syndromes with ST segment elevation; ST (−): Acute Coronary Syndromes without ST segment elevation
  2. *Statistically significant (Chi square test)